News-Medical.Net on MSN
Runx1 overexpression triggers early intervertebral disc degeneration
A new research paper was published in Volume 17, Issue 9 of Aging-US on September 8, 2025, titled, "Runx1 overexpression ...
Findings from an interim analysis showed CELZ-201-DDT statistically significantly reduced pain and improved mobility in patients with chronic lower back pain. The Food and Drug Administration (FDA) ...
Vivex Biologics, a leader in developing and delivering innovative allografts, today announced that it has treated the first ...
Insurance denied 18-year-old Nala White’s surgery for degenerative disc disease. After NBC News reached out, it was approved the next day. By the time she graduated high school, the back pain that ...
Hosted on MSN
Retail Traders Pile Into Creative Medical After FDA Fast Tracks Degenerative Disc Disease Therapy
Retail chatter around Creative Medical Technology Holdings picked up on Wednesday after the company said the U.S. Food and Drug Administration (FDA) had granted Fast Track status to its lead ...
Spine BioPharma Announces Topline Results from Phase 3 MODEL Trial For SB-01 (vicatertide) In Chronic Low Back Pain Associated with Degenerative Disc Disease Spine BioPharma, Inc. announced today the ...
Tiger Woods has undergone his 7th back surgery following a collapsed disc, a condition where the cushioning disc between ...
Although 67% of participants treated with SB-01 achieved the primary endpoint at 6 months, the difference when compared with sham treatment was not statistically significant. Topeline data were ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback